Kalina Kamenova, PhD - Founder and Research Director
Dr. Kamenova's research interests are broadly interdisciplinary and include science and technology policy, science and health communication, media representations of the emerging technologies in biomedicine, public health innovation, bioethics, deliberative democracy, citizen engagement, and community-based participatory research. She is an engaged scholar, who founded the Canadian Institute for Genomics and Society to advance public knowledge of ethical and policy dilemmas arising from the emerging genomic, stem cell and assisted reproductive technologies and increase social responsibility in biomedical research and innovation. Dr. Kamenova has previously held an Assistant Professor appointment in the Bachelor of Arts and Science Program at Trent University, where she developed an integrated curriculum in the area of science, technology and society bridging the divide between the humanities and the sciences. Prior to this faculty position, she contributed to large-scale multidisciplinary projects in health law and science policy, focusing on the emerging technologies, as an Academic Research Associate in the Health Law Institute at the University of Alberta. Dr. Kamenova also served as the Inaugural Research Director of the Center for Public Involvement at the University of Alberta - a community-university partnership for excellence in the scholarship and practice of public involvement, and was appointed as Adjunct Professor in the Faculty of Extension. In this role, she led multiple participatory research projects and collaborated with the City of Edmonton on public engagement initiatives on municipal policy issues such as Internet voting, climate change, urban food, and youth civic participation. Dr. Kamenova received her PhD in Social and Political Thought from York University in Toronto in 2012, with a dissertation on the public communication and bio-politics of human embryonic stem cell research in the United States and the European Union. Her research has received international recognition through numerous publications in high-impact journals and speaking engagements. She has developed and taught courses in bioethics, science and technology studies, science communication, scientific controversies, and scientific and technical writing at McMaster University, Trent University, York University, and the University of Ontario Institute of Technology.
Shashank Tiwari, PhD - Research Fellow
Dr. Tiwari's research focuses on the social studies of life sciences, biomedicine and emerging biomedical technologies. He completed an MPhil in Science Policy Studies at Jawaharlal Nehru University in India and a PhD in Science and Technology Studies (STS) at the University of Nottingham in the United Kingdom. His dissertation, supported with a Wellcome Trust Fellowship, examined the nature of stem cell activities in India, focusing on how key stakeholders generate expectations around stem cell therapies and frame key ethical concerns, and why the biomedical governance system fails to regulate these emerging practices. It used qualitative methodologies such as surveys, document and policy analysis, and interviews with key scientists, clinicians, industry representatives and policymakers. Dr. Tiwari has published a significant numbers of journal articles and book chapters on the governance of stem cell research and therapy in India, including research papers in prestigious journals such as New Genetics and Society and Regenerative Medicine that were recognized as important contributions by leading scholars in the field.
Samuel J. Ujewe, PhD - Research Fellow
Dr. Ujewe's research interests are in the areas of bioethics and population health, focusing on inequities in global health, health and social justice, cross-cultural bioethics and applied ethics. His research integrates equity theory and indigenous moral principles to enhance policies, programs and heath services for vulnerable and under-served populations. Dr. Ujewe holds a PhD in Bioethics & Health Policy from the University of Central Lancashire in United Kingdom and has previously served as a Post-doctoral Fellow at McMaster University in Hamilton, Canada, where he provided ethics consultation for the Bill & Melinda Gates Foundation on global health research and interventions projects. He is currently pursuing a research project on moral residue and health justice for under-served populations in the Global South. Dr. Ujewe is a Fellow and Sub-Faculty Chair at the Global Emerging Pathogen Treatment Consortium (GET-Africa), leading projects and research within the Cultural, Anthropological, Social, and Economic Impact (CASE) Work Group. He is an Associate Fellow of the UK Higher Education Academy (HEA) and a member of the International Forum of Teachers of Ethics, Bioethics and Medical Law (IFT). Dr. Ujewe is Co-editor of the forthcoming book "Socio-cultural Dimensions of Emerging Infectious Diseases in Africa: An Indigenous Response to Deadly Epidemics," which will be released by Springer Nature Publishers in July 2019.
Dr. Li Du, External Research Fellow
Dr. Li Du is an Assistant Professor in the Faculty of Law at the University of Macau. His teaching and research interests include international law, health law, biotechnology law and policy. Before joining the University of Macau, he worked as a Research Associate in the Health Law Institute at the University of Alberta, Canada, where he contributed to national research projects in health law and science policy. Dr. Du graduated from Wuhan University, China with a dual Bachelor's degree in Law and Clinic Medicine in 2005 and received his Doctorate in Law from the Faculty of Law, University of Alberta in 2014. Dr. Du was a Fellow in the Canadian Institutes for Health Research Health Law and Policy Program and a Visiting Scholar in the Brocher Foundation in Geneva, Switzerland. He has published peer-reviewed articles in leading academic journals and presented his research at international conferences. Dr. Du's current research explores the regulation of direct-to-consumer genetic testing for non-disease purposes in China.